1-7 of 7
Michael Dechant
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Recombinant Dimeric IgA Antibodies as Tumor-Specific Agents.

Michael Dechant, MD, Stefan Lohse, PhD, Stefanie Derer, PhD, Thomas Beyer, PhD, Katja Klausz, PhD, Matthias Peipp, PhD, Jeanette H. W. Leusen, PhD, Jan G. J. van de Winkel, PhD, Thomas Valerius, MD
Journal: Blood
Blood (2010) 116 (21): 1488.
https://doi.org/10.1182/blood.V116.21.1488.1488
Published: 2010
Journal Articles

Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells

Matthias Peipp, Jeroen J. Lammerts van Bueren, Tanja Schneider-Merck, Wim W. K. Bleeker, Michael Dechant, Thomas Beyer, Roland Repp, Patrick H. C. van Berkel, Tom Vink, Jan G. J. van de Winkel, Paul W. H. I. Parren, Thomas Valerius
Journal: Blood
Blood (2008) 112 (6): 2390–2399.
https://doi.org/10.1182/blood-2008-03-144600
Published: 2008
Includes: Supplemental data
Journal Articles

Recombinant Chimeric IgA1 and IgA2 Antibodies for Tumor Immunotherapy.

Michael Dechant, MD, Thomas Beyer, PhD, Stefan Lohse, Tanja Schneider-Merck, PhD, Wencke Weisner, Sven Berger, PhD, Matthias Peipp, PhD, Jan G.J. van de Winkel, PhD, Thomas Valerius, MD
Journal: Blood
Blood (2007) 110 (11): 4892.
https://doi.org/10.1182/blood.V110.11.4892.4892
Published: 2007
Journal Articles

A Humanized HLA-DR Antibody (HU1D10, Apolizumab) in Combination with G-CSF (Filgrastim) for the Treatment of Non-Hodgkin’s Lymphoma: A Pilot Study.

Juergen Rech, MD, Roland Repp, MD, Dorit Rech, MD, Bernhard Stockmeyer, MD, Michael Dechant, MD, Gerald Niedobitek, MD, Tilman Pearce, MD, Georg Weiner, MD, Martin Gramatzki, MD, Thomas Valerius, MD.
Journal: Blood
Blood (2005) 106 (11): 4775.
https://doi.org/10.1182/blood.V106.11.4775.4775
Published: 2005
Journal Articles

Heterogeneous Expression of the 158V and 158F Alleles in FcγRIIIA Heterozygous Donors.

Michael Dechant, Thomas Poellot, Ulrich Kunzendorf, Thomas Valerius
Journal: Blood
Blood (2004) 104 (11): 1362.
https://doi.org/10.1182/blood.V104.11.1362.1362
Published: 2004
Journal Articles

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

Jessica L. Teeling, Ruth R. French, Mark S. Cragg, Jeroen van den Brakel, Marielle Pluyter, Haichun Huang, Claude Chan, Paul W. H. I. Parren, C. Erik Hack, Michael Dechant, Thomas Valerius, Jan G. J. van de Winkel, Martin J. Glennie
Journal: Blood
Blood (2004) 104 (6): 1793–1800.
https://doi.org/10.1182/blood-2004-01-0039
Published: 2004
Journal Articles

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

Michael Dechant, Gestur Vidarsson, Bernhard Stockmeyer, Roland Repp, Martin J. Glennie, Martin Gramatzki, Jan G. J. van de Winkel, Thomas Valerius
Journal: Blood
Blood (2002) 100 (13): 4574–4580.
https://doi.org/10.1182/blood-2002-03-0687
Published: 2002